Sotera Health (NASDAQ:SHC) Shares Purchased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its position in Sotera Health (NASDAQ:SHC - Free Report) by 18.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 1,348,917 shares of the company's stock after purchasing an additional 208,914 shares during the period. Charles Schwab Investment Management Inc. owned 0.48% of Sotera Health worth $22,527,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. William Blair Investment Management LLC raised its holdings in shares of Sotera Health by 0.6% in the second quarter. William Blair Investment Management LLC now owns 1,131,455 shares of the company's stock valued at $13,430,000 after buying an additional 6,707 shares during the last quarter. Clearline Capital LP purchased a new stake in Sotera Health during the 2nd quarter valued at approximately $1,707,000. First Pacific Advisors LP acquired a new stake in Sotera Health during the 2nd quarter worth approximately $540,000. Darsana Capital Partners LP purchased a new position in shares of Sotera Health in the 2nd quarter valued at approximately $29,074,000. Finally, Bank of New York Mellon Corp raised its stake in shares of Sotera Health by 3.9% during the second quarter. Bank of New York Mellon Corp now owns 1,004,046 shares of the company's stock worth $11,918,000 after purchasing an additional 37,681 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SHC has been the topic of a number of analyst reports. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research report on Friday. They issued a "neutral" rating and a $14.00 price objective on the stock. Citigroup boosted their price target on shares of Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a research note on Wednesday, November 6th. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $17.00 price objective on shares of Sotera Health in a research report on Thursday, November 21st. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $16.08.

Sotera Health Trading Up 1.2 %

Shares of SHC stock traded up $0.16 during mid-day trading on Friday, hitting $13.14. 844,304 shares of the company's stock were exchanged, compared to its average volume of 1,342,936. The stock has a market cap of $3.72 billion, a price-to-earnings ratio of 51.90 and a beta of 1.96. The stock has a 50-day simple moving average of $14.96 and a two-hundred day simple moving average of $14.06. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.44. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The company had revenue of $285.47 million for the quarter, compared to analyst estimates of $278.64 million. During the same period last year, the company posted $0.18 EPS. The business's revenue for the quarter was up 8.5% on a year-over-year basis. Equities analysts expect that Sotera Health will post 0.61 EPS for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.